We use cookies to improve your experience and for marketing. Read our cookie policy or manage cookies.

Accept essential cookies
Accept all cookies
Sign in
Sign in
Companies → Morgan Stanley China A Share Fu
Save to list
Remove

Morgan Stanley China A Share Fu

United States, New York
Report a bug?
Claim ownership and edit
Description
Morgan Stanley China A Share Fund, Inc. is a closed ended equity mutual fund launched and managed by Morgan Stanley Investment Management Inc. It is co-managed by Morgan Stanley Investment Management Company. The fund invests in the public equity markets of China. It seeks to invest in the stocks of companies operating across diversified sectors. The fund invests in the growth stocks of companies. It employs fundamental analysis with bottom-up stock picking approach to create its portfolio. The fund benchmarks the performance of its portfolio against the Morgan Stanley Capital International China A Share Index. Morgan Stanley China A Share Fund, Inc. was formed on July 6, 2006 and is domiciled in the United States.
Industries
SIC
Address:

1585 Broadway

Website:
Recent news:

Rome Expands Tram Fleet with New CAF Trams

Rome's transit operator ATAC modernizes fleet with new CAF trams, replacing aging vehicles.

Source: IndexBox Mar 10, 2026

Latvia Awards €89.4M Contract to Škoda Group for Battery-Electric Trains

Latvia's transport authority ATD has signed a major contract with Škoda Group for nine battery-electric trainsets, funded by national and EU funds, to modernize regional services and reduce travel times, with entry into service planned for 2029.

Source: IndexBox Dec 15, 2025

CAF Wins Sao Paulo Suburban Train Maintenance Contract

CAF secures a major 24-year contract to maintain 107 trains on Sao Paulo's suburban network, utilizing its LeadMind digital platform for condition-based monitoring.

Source: IndexBox Nov 26, 2025

Applied Materials Stock Rises After Analyst Upgrades

An overview of Applied Materials' recent stock surge driven by positive analyst upgrades and revised price targets, highlighting its strong year-to-date performance.

Source: IndexBox Oct 13, 2025

Moderna Stock Drops on Pfizer-BioNTech Vaccine News

Moderna stock dropped nearly 5% following a competitive vaccine update from Pfizer-BioNTech and its own distant 2028 profitability target, contributing to a 42.9% YTD decline.

Source: IndexBox Sep 8, 2025

Resideo Technologies Stock Surges 12.9% After Morgan Stanley Upgrade

Resideo Technologies' stock soared 12.9% following a Morgan Stanley upgrade and strong Q2 results, with revenue up 22% YoY. The company also resolved a Honeywell indemnification agreement, boosting investor confidence.

Source: IndexBox Aug 12, 2025

XNYS - Delayed Quote - USD
CAF
17.07 -0.56 (-3.18%)
At close March 23 03:38 UTC
Candle
Line
1D
5D
1M
6M
1Y
5Y
Financial Statistics
Valuation Measures
Current
Quarterly
As of 06/22/2025
Market Cap: 227.93 M
Enterprise Value: N/A
Trailing P/E: 11.96
Forward P/E: N/A
PEG Ratio (5yr expected): N/A
Price/Sales (ttm): 12.20
Price/Book (mrq): 0.85
Enterprise Value/Revenue: 12.20
Enterprise Value/EBITDA: N/A
Financial Highlights
Profitability and Income Statement
Profit Margin: N/A%
Return on Assets (ttm): N/A%
Return on Equity (ttm): N/A%
Revenue (ttm): N/A
Net Income Avi to Common (ttm): N/A
Diluted EPS (ttm): 1.11
Balance Sheet and Cash Flow
Total Cash (mrq): N/A
Total Debt/Equity (mrq): N/A%
Levered Free Cash Flow (ttm): N/A
Disclaimer:

IndexBox is not affiliated with, associated with, or endorsed by this company in any way. The information provided on this page, including company details, is solely for informational purposes. IndexBox makes no representations or warranties about the accuracy or completeness of the information provided.

All data and information is provided “as is” for informational purposes only, and is not intended for trading purposes or financial, investment, tax, legal, accounting or other advice. Please consult your broker or financial representative to verify pricing before executing any trade. IndexBox is not an investment adviser, financial adviser or a securities broker. None of the data and information constitutes investment advice nor an offering, recommendation or solicitation by IndexBox to buy, sell or hold any security or financial product, and IndexBox makes no representation (and has no opinion) regarding the advisability or suitability of any investment.